40mg Cytopoint (lokivetmab) is a monoclonal antibody injection designed to provide long-lasting relief from itching caused by atopic dermatitis in dogs. Unlike traditional treatments such as steroids or antihistamines, Cytopoint specifically targets and neutralises interleukin-31 (IL-31), a key protein responsible for triggering itching and inflammation in allergic skin conditions.
Each Cytopoint vial contains 40mg of lokivetmab and is administered as a subcutaneous injection by a veterinarian. The effects last for four to eight weeks, offering extended relief from symptoms. Cytopoint is a prescription medication and should only be used under veterinary supervision.
40mg Cytopoint is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Cytopoint is an innovative biological therapy that works differently from conventional allergy treatments. It contains a caninised monoclonal antibody that specifically binds to and neutralises interleukin-31 (IL-31), a cytokine involved in sending itch signals to the brain.
By blocking IL-31, Cytopoint prevents the itch response before it begins, reducing the need for dogs to scratch excessively. Unlike steroids or immunosuppressive drugs, which have a broad impact on the immune system, Cytopoint precisely targets the underlying cause of itching without disrupting other bodily functions.
This targeted approach allows Cytopoint to provide fast and effective relief while minimising the risk of side effects. The injection begins to work within 24 hours and can last for up to eight weeks, making it a convenient and well-tolerated option for dogs with chronic allergic skin conditions.
